Airlines could save hundreds of millions in fuel costs as the growing use of weight-loss drugs reduces average passenger weight, delivering an unexpected boost to efficiency across global fleets.

For UK business travel, this development could help airlines better manage costs, supporting more stable fares, improved sustainability performance and greater long-term resilience in corporate travel programmes.